1 |
McNeill AM, Rosamond WD, Girman CK, Golden SH, Schmidt ML, East HE, Rhys Williams G (2005): The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 28(2): 385-390
DOI
ScienceOn
|
2 |
Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO, Criqui M (2003): Markers of inflamation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American heart association. Circulation 107(3): 499-511
DOI
ScienceOn
|
3 |
Facchini F, Chen YD, Reaven GM (1994): Light-to-moderate alcohol intake is associated with enhanced insulin sensitivity. Diabetes Care 17(2): 115-119
DOI
ScienceOn
|
4 |
Frohlich M, Imhof A, Berg G, Hutchinson WL, Pepys MB, Boeing H, Muche R, Brenner H, Koenig W (2000): Association between C-reactive protein and features of the metabolic syndrome: a population-based study. Diabetes Care 23(12): 1835-1839
DOI
ScienceOn
|
5 |
Tracy RP, Lemaitre RN, Psaty BM, Lves DG, Evans RW, Cushman M, Meilahn EN, Kuller LH (1997): Relationship of C-reactive protein to risk of cardiovascular disease in the elderly. Results from the Cardiovascular Health Study and the Rural Health Promotion Project. Arterioscler Thromb Vasc Biol 17(6): 1121-1127
DOI
ScienceOn
|
6 |
Ridker PM, Buring JE, Cook NR, Rifai N (2003): C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American women. Circulation 107(3): 391-397
DOI
ScienceOn
|
7 |
Ridker PM, Wilson PW, Grundy SM (2004): Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk? Circulation 109(23): 2818-2825
DOI
ScienceOn
|
8 |
Solymoss BC, Bourassa MG, Campeau L, Sniderman A, Marcil M, Lesperance J, Levesque S, Varga S (2004): Effect of increasing metabolic syndrome score on atherosclerotic risk profil and coronary artery disease angiographic severity. Am J Cardiol 93(2): 159-164
DOI
ScienceOn
|
9 |
Sower JR (2003): Obesity as a cardiovascular risk factors. Am J Med 115(8A): 37-44
|
10 |
Stern MP, Williams K, Haffer SM (2002): Identification of persons at high risk for type 2 diabetes mellitus: Do we need the oral glucose tolerance test? Ann Inter Med 136(8): 575-581
DOI
ScienceOn
|
11 |
Wamala SP, Lynch J, horsten M, Mittleman MA, Schench-Gustafsson K, Orth-Gomer K (1999): Education and the metabolic syndrome in women. Diabetes Care 22(12): 1999-2003
DOI
ScienceOn
|
12 |
WHO WPR (2000): The Asia-Pacific perspective: Redefining obesity and its treatment, Sydney, Australia, World Health Organization Western Pacific Region
|
13 |
Lim S, Lee HK, Kim KC, Park C, Shin C, Cho NH (2006): Submitted to journal of endocrinological investigation a ruralurban comparison of the characteristics of metabolic syndrome by gender in Korea: The Korea Health and Denome Study (KHGS). J Endocrinol Invest 29(4): 303-319
|
14 |
Park JS, Park HD, Yun JW, Jung CH, Lee WY, Kim SW (2002): Prevalence of the metabolic syndrome as defined by NCEP-APT among the urban Korean population. Korean J Med 63(3): 290-298
|
15 |
Marroquin OC, Kip KE, Kelley DE, Johnson BD, shaw LJ, Bairey Merz CN, Sharaf BL, Pepine CJ, Sopko G, Reis SE (2004): Metabolic syndrome modifies the cardiovascular risk associated with angiographic coronary artery disease in women: A report from the women's ischemia syndrome evaluation. Circulation 109(6): 714-721
DOI
ScienceOn
|
16 |
Meshkani R, Taghikhani M, Larijani B, Khatami B, Khatami S, Khoshbin E, Adeli K (2006): The relationship between homeostasis model assessment and cardiovascular risk factors in Iranian subjects with normal fasting glucose and normal glucose tolerance. Clin Chim Acta 371(2): 169-175
DOI
ScienceOn
|
17 |
Nakanishi N, shirishi T, Wada M (2005): Association between fasting glucose and C-reactive protein in a Japanese population: the Minoh study. Diabetes Research and Clinical Practice 69(1): 88-98
DOI
ScienceOn
|
18 |
Reaven GM (1998): Role of insulin resistance in human disease. Diabetes 37(12): 1595-1607
|
19 |
Roberts WL (2004): CDC/AHA wirkshop on marlers of inflammation and cardiovascular disease: Application to clinical and public health practice: laboratory tests available to assess inflammation-performance and standardization. Circulation 110(25): 572-576
DOI
ScienceOn
|
20 |
Ridker PM, Stampfer MJ, Rifai N (2001): Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285(19): 2481-2485
DOI
ScienceOn
|
21 |
Ford ES, Galuska DA, Gillespie C, Will JC, Giles WH, Dietz WH (2001): C-reactive protein and body mass index in children; findings from the national health and nutrition examination survery. 1998-1994. J Pediatr 138(4): 486-492
DOI
ScienceOn
|
22 |
Isomaa P, Almaren P, Tuomi T, Forsen B, Lahti K, Nissen M (2001): Cardiovascular morbidity and associated with the metabolic syndrome. Diabetes Care 24(4): 683-689
DOI
ScienceOn
|
23 |
Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, O'Reilly DS, Packard CJ, Sattar N (2002): C-Reactive protein is an independent predictor of risk for the development of diabetes in the west of scotland coronary prevention study. Diabetes 51(5): 1596-1600
DOI
ScienceOn
|
24 |
Grundy SM, Cleeman JL, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC, Spertus JA, Costa F (2005): American heart association; national heart, lung, and blood institute, diagnosis and management of the metabolic syndrome: an American heart association/national heart, lung, and blood institude scientific statement. Circulation 112: 2735-2752
DOI
ScienceOn
|
25 |
Hsieh SD, Muto T (2006): Metabolic syndrome in Japanese men and women with special reference to the anthropometric criteria for the assessment of obesity: Proposal to use the waist-to-height ratio. Prev Med 42(2): 135-139
DOI
ScienceOn
|
26 |
JNC (2003): The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
|
27 |
KIMS POC (Point of Care) (2007): Current data of HDL in Korean and new proposal to define role of HDL in Korean. Available from http://www.kimsonline.co.kr
|
28 |
KOSSO (2005): Korean Society for the Study of Obesity
|
29 |
Kwon HS, Park YM, Lee HJ, Lee JH, Choi YH, Ko SH, Lee JM, Kim SR, Kang SY, Lee WC, Ah MS (2005): The prevalence and clinical characteristics of the metabolic syndrome in middleaged Korean adults. Korean J Med 68(4): 359-369
|
30 |
Ahn SK, Chun BY, Kam S, Jin DG, Kim JY (2002): Serum total cholesterol levels and related factors in a rural adult population. J Prev Med Pub Health 35(3): 256-262
과학기술학회마을
|
31 |
Aguilar D, Fisher MR, O'Connor CM, Dunne MW, Muhlestein JB, Yao L, Gupta S, Benner RJ, Cook TD, Edwards D, Pfeffer MA (2006): Metabolic syndrome, C-reactive protein, and prognosis in patients with established coronary artery disease. Am Heart J 152: 298-304.
DOI
ScienceOn
|
32 |
Albert MA (2000): The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 2(4): 274-279
DOI
ScienceOn
|
33 |
Berenson GS, Srinivasan SR, Bao W, Newman WP, Tracy RE, Wattigney WA (1998): Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338(23): 1650-1656
DOI
ScienceOn
|
34 |
Blake GJ, Ricker PM (2003): C-reactive protein and other inflammatory risk markers in acute coronary syndrome. J Am College Cardiology 41(4): 37-42
DOI
ScienceOn
|
35 |
Castelli WP (1998): Cholesterol and lipids in the risk of coronary heart disease: The framingham heart study. Can J Cardiol 4: 5A-10A
|